6-BROMO-2H-BENZO[B][1,4]THIAZIN-3(4H)-ONE, 97.0%, 5g

ethyl 2-benzoylpentanoate, 5g

(S)-2-AMINOBUT-3-YN-1-OL HCL, 95.0%, 250mg

(2R,3S,4S,5R,6R)-2-(Hydroxymethyl)-6-(nonyloxy)tetrahydro-2H-pyran-3,4,5-triol, 95.0%, 5g

1-Bromo-3-(difluoromethyl)benzene, 95.0%, 1g

(4-Bromophenyl)(cyclopropyl)methanamine, 95.0%, 100mg

4-(4-piperidinyl)-2(1H)-pyridinone dihydrochloride, 95.0%, 250mg

1,2-dimetoxietano, mínimo 99 %, para síntesis, 500 ml, envase de vidrio

C-[1,4]Dioxan-2-yl-methylamine, 95.0%, 5g

2-Cyclobutyl-2-phenylacetic acid, 98%, 500mg

(1R,3s,5S)-Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate, 95.0%, 1g

4-BROMO-3-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE, 95%, 1g

4-(4-methoxyphenyl)-1,3-dimethyl-1H-pyrazol-5-amine, 95.0%, 10g